compound glp-1 fda What Changed? The FDA's Clarification on Compounded Drugs FDA moves to remove GLP-1

Shapsis Why Some Patients Cannot Tolerate GLP-1 Weight Loss Medications Many patients start medications such as Semaglutide or Tirzepatide to help with weight loss

As soon as bioidentical hormones are introduced, many symptoms usually subside, and patients begin to feel like themselves again

Urva, et al., LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept, 2022, Cell Metabolism 34, 12341247

[VISIBLE RESULTS] Expect noticeable improvements in 412 weeks with consistent usefuller, thicker hair ahead.

Association of the OCTN1/1672T variant with increased risk for colorectal cancer in young individuals and ulcerative colitis patients